GvdBGuido van den BerkMD, PhDVideoHIVGlobal HIV Clinical Forum 2018Designing e-health interventions for HIV care | Guido van den Berk, MD, PhDView Video
VideoHIVGlobal HIV Clinical Forum 2018Clinical case: Integrase Inhibitors in Africa | Julia Turner, MDView Video
RZRebecca ZashMDVideoHIVGlobal HIV Clinical Forum 2018Implication of the resent Dolutegravir data | Rebecca Zash, MDView Video
DKDaniel KuritzkesMDVideoHIVGlobal HIV Clinical Forum 2018What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MDView Video
MSMauro SchechterMD, PhDVideoHIVGlobal HIV Clinical Forum 2018State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhDView Video
APAnton PozniakMD, FRCPSlidesetHIVGlobal HIV Clinical Forum 2018What is the Clinical support for reduce drug regimens? | Anton Pozniak, MD, FRCPView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2018One pill a day?: Integration novel delivery systems into routine care | Terry Blaschke, MDView Slideset
MSMauro SchechterMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhDView Slideset
GvdBGuido van den BerkMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018Designing e-health interventions for HIV care | Guido van den Berk, MD, PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2018Clinical case: Integrase Inhibitors in Africa | Julia Turner, MDView Slideset
RZRebecca ZashMDSlidesetHIVGlobal HIV Clinical Forum 2018Implication of the resent Dolutegravir data | Rebecca Zash, MDView Slideset
MPMiłosz ParczewskiMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018Expanding Integrase Inhibitors in the rest of Europe | Miłosz Parczewski, MD, PhDView Slideset
